Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neuphoria Therapeutics (NEUP) Operating Expenses (2024 - 2025)

Historic Operating Expenses for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q4 2025 value amounting to $4.1 million.

  • Neuphoria Therapeutics' Operating Expenses fell 699.49% to $4.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $18.6 million, marking a year-over-year increase of 13390.72%. This contributed to the annual value of $16.8 million for FY2025, which is 622.52% down from last year.
  • According to the latest figures from Q4 2025, Neuphoria Therapeutics' Operating Expenses is $4.1 million, which was down 699.49% from $5.7 million recorded in Q3 2025.
  • In the past 5 years, Neuphoria Therapeutics' Operating Expenses ranged from a high of $5.8 million in Q2 2025 and a low of $3.0 million during Q1 2025